Schreiner MediPharm Introduces Innovative Cut-Through Indicator for Tamper Evidence

• Schreiner MediPharm has developed a novel cut-through indicator for closure seals, enhancing tamper evidence in pharmaceutical packaging.

• The feature is customisable, meets ISO 21976 standards, and adheres to the European Falsified Medicines Directive.

Schreiner MediPharm, a specialist in functional labels for the healthcare sector, has introduced an innovative cut-through indicator function for pharmaceutical closure seals. This advanced feature reveals tampering attempts, such as cutting and resealing, making such actions clearly visible and irreversible.

This new solution is modular and designed to integrate seamlessly into existing or newly developed closure seals. Customisable to suit various applications, the cut-through indicator provides a cost-efficient way to adapt to different materials and designs. It also satisfies strict security requirements, including ISO 21976 and the European Falsified Medicines Directive 2011/62/EU.

Notable features include conspicuous die-cutting contours, flexible strips that reveal tampering, and optional enhancements like raised structures or graphic authentication elements. These features address the critical need for supply chain security by preventing illegal drug tampering and ensuring product integrity.

Counterfeit or tampered drugs pose significant threats, not only endangering patient health but also damaging the reputation of pharmaceutical companies. Ensuring supply chain security is critical for preventing tampering and the illegal substitution of genuine medicines. Schreiner MediPharm reinforces pharmaceutical supply chain integrity through tailored security solutions like the cut-through indicator. This technology helps maintain the quality and efficacy of medications, ensuring they safely reach patients without compromise.